VOLITIONRX LIMITED
1 Scotts Road
#24-05 Shaw Centre
Singapore 228208
October 11, 2018
SUBMITTED VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Dorrie Yale
Re:VolitionRx Limited Acceleration Request
Registration Statement on Form S-3
File No. 333-227731
Requested Date:October 15, 2018
Requested Time:5:00 P.M. Eastern Time
Dear Ms. Yale:
Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.
Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4136 or via email atmalcser@sycr.com.
Sincerely,
VOLITIONRX LIMITED
/s/ Cameron Reynolds
Cameron Reynolds
President and Chief Executive Officer
cc:
Stradling Yocca Carlson & Rauth, P.C.
Marc G. Alcser, Esq.
